$191.5M in total Medicare payments across 5 years
Procedure J7170 (Injection, emicizumab-kxwh, 0.5 mg) received $191.5M in total Medicare payments.
Across 4.5M services, the average Medicare payment was $42.88 per service.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | YoY Change |
|---|---|---|---|
| 2019 | $20.1M | 436.1K | — |
| 2020 | $30.3M | 618.9K | +50.4% |
| 2021 | $37.9M | 811.1K | +25.3% |
| 2022 | $53.0M | 1.3M | +39.8% |
| 2023 | $50.2M | 1.3M | -5.3% |
| # | Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|---|
| 1 | Accredo Health Group Inc | Pharmacy | PA | $20.1M | 523.7K | $38.41 |
| 2 | Caremark, L.L.C. | Pharmacy | CA | $7.4M | 192.2K | $38.32 |
| 3 | Red Chip Of Nevada | Pharmacy | CA | $7.0M | 177.5K | $39.62 |
| 4 | Hemophilia Of Georgia | Pharmacy | GA | $6.1M | 152.9K | $39.61 |
| 5 | Cascade Hemophilia Consortium | Pharmacy | MI | $5.1M | 129.6K | $39.60 |
| 6 | Procare Pharmacy Direct, Llc. | Pharmacy | PA | $4.5M | 117.8K | $38.26 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.